Add like
Add dislike
Add to saved papers

Noble-metal-free Fe-N/C catalyst for highly efficient oxygen reduction reaction under both alkaline and acidic conditions.

In this work, we report the synthesis and assessment of a new non-precious-metal oxygen reduction reaction (ORR) catalyst from pyrolysis of an iron-coordinated complex which manifests superior activity in both alkaline and acidic media. 11,11'-bis(dipyrido[3,2-a:2',3'-c]phenazinyl) (bidppz) was selected as a ligand for the formation of a nitrogen-rich iron-coordinated coordination polymer (Fe-bidppz) which forms a self-supporting catalyst containing high densities of nitrogen and iron doping by pyrolysis. The catalyst pyrolyzed at 800 °C (Fe-N/C-800) shows the highest ORR activity with onset and half-wave potentials of 923 and 809 mV in 0.1 M KOH, respectively, which are comparable to those of Pt/C (half-wave potential 818 mV vs RHE) at the same catalyst loading. Besides, the Fe-N/C-800 catalyst has an excellent ORR activity with onset and half-wave potentials only 38 and 59 mV less than those of the Pt/C catalyst in 0.1 M HClO4. The optimal Fe-N/C-800 catalyst displays much greater durability and tolerance of methanol than Pt/C. We propose that the Fe-N/C-800 catalyst has a considerably high density of surface active sites because Fe-N/C-800 possesses excellent ORR activity while its specific surface area is not so high. Electrochemical measurements show that the Fe-N/C-800 catalyst in KOH and HClO4 follows the effective four-electron-transfer pathway.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app